BridgeBio Pharma (BBIO) Profit After Tax (QoQ) (2018 - 2026)
BridgeBio Pharma (BBIO) Profit After Tax (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,719.23 Bn | 65,718.94 Bn | - |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 470.97 Bn | 466.18 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.29 Bn | 115.05 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.98 Bn | 61.22 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.06 Bn | 62.06 Bn | - |
| 8 | Argenx Se | 55.78 Bn | 50.60 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.43 Bn | 34.42 Bn | 959.66 Mn |
| 10 | BridgeBio Pharma | 16.40 Bn | 15.46 Bn | 184.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.43% |
| Dec 31, 2025 | -5.24% |
| Sep 30, 2025 | -0.64% |
| Jun 30, 2025 | -8.34% |
| Mar 31, 2025 | 36.57% |
| Dec 31, 2024 | -62.79% |
| Sep 30, 2024 | -117.43% |
| Jun 30, 2024 | -108.92% |
| Mar 31, 2024 | 78.77% |
| Dec 31, 2023 | 5.10% |
| Sep 30, 2023 | -11.69% |
| Jun 30, 2023 | -12.59% |
| Mar 31, 2023 | -1.54% |
| Dec 31, 2022 | -0.27% |
| Sep 30, 2022 | -5,378.43% |
| Jun 30, 2022 | 98.73% |
| Mar 31, 2022 | -32.21% |
| Dec 31, 2021 | 5.42% |
| Sep 30, 2021 | -57.74% |
| Jun 30, 2021 | 40.34% |